{"id":"W4283701030","doi":"10.1136/annrheumdis-2022-eular.2030","title":"POS1044 GUSELKUMAB PROVIDES CONSISTENT AND DURABLE PAIN IMPROVEMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF 2 PHASE 3, RANDOMIZED, CONTROLLED CLINICAL TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Research and Development; Sun Pharma; University College Dublin; Celgene; Gilead Sciences; Pfizer Canada; Sanofi; Amgen; Pfizer; University of Washington; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Placebo; Psoriatic arthritis; Visual analogue scale; Internal medicine; Physical therapy; Ankylosing spondylitis; Arthritis; Alternative medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003673589,0.001998181,0.004271292,0.0006355158,0.0006306646,0.001409951,0.001023639,0.002483168,0.00585107],"category_scores_gemma":[0.00207807,0.0007782896,0.003409565,0.0008232099,0.001523065,0.001765506,0.0004076736,0.004089839,0.001174278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006819115,"about_ca_system_score_gemma":0.0008342087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007577748,"about_ca_topic_score_gemma":0.002102529,"domain_scores_codex":[0.9987619,0.0006374418,0.000101235,0.0001695851,0.0001304339,0.0001994482],"domain_scores_gemma":[0.998793,0.0004174998,0.0003262558,0.0001004622,0.00009275042,0.0002700516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8900541,0.01409172,0.001401819,0.002683316,0.004215342,0.00008716151,0.0001166893,0.0005606472,0.007097353,0.0001673522,0.002307846,0.07721665],"study_design_scores_gemma":[0.9004682,0.09184052,0.004374667,0.000116272,0.001156483,0.00007540156,0.000047871,0.0002927422,0.0005578715,0.0001543399,0.0008828968,0.00003261416],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9564978,0.03167589,0.001462348,0.001685539,0.0008702032,0.00267305,0.001640441,0.0003223038,0.003172337],"genre_scores_gemma":[0.9729635,0.01465685,0.002363208,0.002590976,0.0007757654,0.002348666,0.00193688,0.00006943628,0.002294752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00585107,"threshold_uncertainty_score":0.01957375,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03881296192731053,"score_gpt":0.3164750820875868,"score_spread":0.2776621201602763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}